儿童体内植入连续流心室辅助装置后的脑卒中:EUROMACS注册分析
该研究回顾性分析EUROMACS数据库中19岁以下使用体内连续流心室辅助装置的患者,按体表面积分为<1.2 m²组和≥1.2 m²组。结果显示两组脑卒中发生率无显著差异,总体脑卒中发生率为0.1次/患者年,提示儿童体内连续流VAD的脑卒中发生率似乎较低。
要点
- 儿童体内连续流VAD的脑卒中总体发生率为0.1次/患者年。
- 体表面积<1.2 m²组未发生脑卒中,≥1.2 m²组发生4例(占该组11%)。
- 两组死亡率与移植率无显著差异。
核心结论
- 儿童体内连续流心室辅助装置的脑卒中发生率(0.1次/患者年)似乎较低,且与体表面积无关。
研究设计与样本
- 回顾性研究,分析EUROMACS数据库中19岁以下使用体内连续流心室辅助装置的患者。
- 按体表面积分组:组1(<1.2 m²,n=13)和组2(≥1.2 m²,n=38)。
主要发现
- 组1无脑卒中发生,组2发生4例脑卒中(占组2的11%,占两组总51例的8%)。
- 组1死亡3例(23%),组2死亡5例(13%)(P=0.21)。
- 组1移植7例(54%),组2移植17例(45%)(P=0.29)。
关键数值与推荐
- 脑卒中总体发生率为0.1次/患者年。
临床怎么用
- 儿童体内连续流VAD的脑卒中风险较低,体表面积较小者未观察到脑卒中。
局限性
- 回顾性注册研究,样本量较小(n=51),可能影响统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Little is known about cerebral strokes in paediatric patients supported by intracorporeal continuous-flow ventricular assist devices. METHODS: We retrospectively investigated patients younger than 19 years of age who were treated with an intracorporeal continuous-flow ventricular assist device in the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) database. The patients were stratified by body surface area in Group 1 [<1.2 m2 (n = 13)] and Group 2 [≥1.2 m2 (n = 38)]. Cerebral strokes, both ischaemic and haemorrhagic, were studied. RESULTS: Of the 2941 patients with ventricular assist device (VAD) implants listed in the database, 124 (4%) patients were less than 19 years of age. Fifty-one of them (2%) were supported with a continuous-flow ventricular assist device. Group 1 (6 female and 7 male) had a mean age (±SD) of 9 ± 2.3 years compared with 15.6 ± 1.8 years in Group 2 (21 female and 17 male). Three (23%) patients died in Group 1 on VAD support, whereas 5 (13%) patients died in Group 2 (P = 0.21; log-rank test). Seven (54%) patients with a VAD in Group 1 and 17 (45%) patients in Group 2 underwent transplantation (P = 0.29); of these, 1 (8%) patient recovered (Group 1) with subsequent device explantation. The other patients, 2 in Group 1 and 16 in Group 2, were still on device support at the time of the analysis. There were no cerebral strokes in Group 1, but 4 cerebral strokes (11% of Group 2, 8% of a total of 51 patients in Groups 1 and 2 combined) occurred in Group 2 (3 patients died; P = 0.26; log-rank test). Taken together, the incidence of cerebral strokes in this paediatric cohort of patients with an intracorporeal VAD was 0.1 per patient-year. CONCLUSIONS: The incidence of cerebral strokes in children with intracorporeal VADs (0.1 per patient-year) seems to be low irrespective of the body surface area.
引用
- Schweiger M, Miera O, de By TMMH, et al. Cerebral strokes in children on intracorporeal ventricular assist devices: analysis of the EUROMACS Registry. Eur J Cardiothorac Surg. 2018. PMID: 29029180. doi:10.1093/ejcts/ezx342
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。